Home › Funds › Birchview Capital, LP › QNCX
Birchview Capital, LP position in QNCX
QUINCE THERAPEUTICS INC · Health Care
Birchview Capital, LP reported holding 40,601 shares of QNCX (QUINCE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.75% of its reported portfolio and ranking #33 among its reported holdings. Birchview Capital, LP first reported this position in Q3 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Birchview Capital, LP's QNCX position evolved
Birchview Capital, LP first disclosed a stake in QNCX in Q3 2026 at 40,601 shares (US$1.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 40.60K | $1.26M | New |
About QNCX and 13F data
QNCX (QUINCE THERAPEUTICS INC) is a Health Care company. 17 other funds we track also report a position in QNCX — the largest reported positions include Squadron Capital Management LLC (US$734K), Cormorant Asset Management, LP (US$100K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QNCX
- Squadron Capital Management LLC 40.38K sh · $734.42K · Q2 2026
- Cormorant Asset Management, LP 5.50K sh · $100.01K · Q2 2026
More on Birchview Capital, LP
FAQ
How long has Birchview Capital, LP held QNCX?
Birchview Capital, LP has disclosed QNCX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Birchview Capital, LP's current position in QNCX?
As of Q3 2026, Birchview Capital, LP holds 40.60K shares of QNCX (QUINCE THERAPEUTICS INC), valued at $1.26M, representing 0.75% of its reported portfolio and ranking #33.
Has Birchview Capital, LP been buying or selling QNCX?
In the latest 13F filing (Q3 2026), Birchview Capital, LP newly opened its position in QNCX.
Which other funds hold QNCX?
Other major institutional holders of QNCX include Squadron Capital Management LLC, Cormorant Asset Management, LP, among 17 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.